Pharmafile Logo
Pharmafocus logo
Advanced Search

PM Society and CIM launch new leadership programme for pharma marketers

June 13, 2025
Sales and Marketing CIM Fellowship, Chartered Institute of Marketing (CIM), Corporate, Marketing Excellence Industry Group, PM Society Awards, Pharmaceutical Marketing (PM) Society, Pharmacy, partnership

The Pharmaceutical Marketing (PM) Society has partnered with the Chartered Institute of Marketing (CIM) to launch the PMS & CIM …

News

Digital platform for hypertension management launches in Europe

June 13, 2025
Business Services, Technical Consultancy Chronic Diseases, HealthTech, Newel Health, digital platform, high blood pressure, hypertension management, hypertension therapy

Newel Health, a European healthtech company specialising in digital medical devices, has announced that Amicomed, its digital platform for hypertension …

News

PL BioScience appoints Oliver Dick as chief technology officer

June 12, 2025
Clinical trials supplies & documentation logistics, Manufacturing and Production, Research and Development Corporate, Devices, Human Platelet Lysate, PL Bioscience, animal-free cell culture, life sciences

PL BioScience, a German life sciences company specialising in the production and development of human platelet lysate (HPL) for cell …

Appointment

Ascend granted certification for quality control testing at Munich facility

June 12, 2025
Contract Manufacturing, Manufacturing Services, Manufacturing and Production Adeno-associated (AAV)-based gene therapy., Ascend Advanced Therapeutics, Devices, Pharmacy, adeno-associated gene therapy, contract development and manufacturing organisation, good manufacturing practice certification, manufacturing site

Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received good manufacturing practice (GMP) certification …

News
handshake

Chiesi partners with Key2Brain to develop therapies for rare neurodegenerative diseases

June 12, 2025
Manufacturing and Production, Mergers and Acquisitions, Research and Development Chiesi Group, Key2Brain, Neurology, Rare Diseases, lysosomal storage disorders, neurodegenerative disease, partnership, ultra-rare disease

Italian biopharma, Chiesi Group, and Key2Brain, a Swedish biotech, have agreed to advance the development of two blood-brain barrier (BBB)-crossing …

News

Treatment for serious eye disease approved in Scotland

June 12, 2025
Market Access, Marketing Services, Research and Development, Sales and Marketing LYTENAVA, Opthalmology, Scottish Medicines Consortium, clinical programme, european union, eye disease, market approval, strategic partnership, united kingdom, wet age-related macular degeneration

Outlook Therapeutics has announced the Scottish Medicines Consortium (SMC) approval of Lytenava (bevacizumab gamma) for the treatment of wet age-related …

News
cellectis

PEPperPRINT launches new peptide microarray platform on 15th anniversary

June 11, 2025
Biotech/start-up, Research and Development, Sales and Marketing Devices, PEPperPRINT, biotech research, peptide microarray platform

German biotech PEPperPRINT has marked its 15th anniversary with the launch of a new peptide microarray platform, combinatorial laser-induced forward …

News

Meteor Biotech opens site at UCLA to support biotech research

June 11, 2025
Biotech/start-up, Research and Development, Sales and Marketing Devices, Immunology, Meteor Biotech, Oncology, Pharmacy, University of California Los Angeles, cell sorting technology, clinical trials, research facility

South Korean spatial omics specialist, Meteor Biotech, has announced the opening of its first international office at the California NanoSystems …

News
handshake_2

BioDuro and Silicogenix collaborate to advance non-traditional drug development

June 11, 2025
Manufacturing Services, Manufacturing and Production, Research and Development BioDuro, Oncology, Pharmacy, Silicogenix, contract research, contract research development and manufacturing organisation (CRDMO), drug development

BioDuro, a contract research, development and manufacturing organisation, has announced a strategic partnership with small molecule design specialist Silicogenix (SGX) …

News
clinical_trials

Dupixent improves symptoms in patients with skin of colour, study shows

June 11, 2025
Advocacy Development, Medical Education, Research and Development Dermatology, Dupixent, Regeneron, Sanofi, atopic dermatitis, dermatology, underserved populations

Sanofi and Regeneron have announced results from the collaborative phase 4 DISCOVER study, presented at the Revolutionizing Atopic Dermatitis Conference, …

News

Lubrizol announces an important milestone for its novelpatented excipient, Apisolex™ polymer

June 10, 2025
Research and Development Apisolex polymer, Good Manufacturing Practices (GMP) guidelines, Lubrizol, Pharmacy, clinical trial

June 10, 2025 – Lubrizol announces that an Apisolex™ polymer excipient-enabled drugformulation is in Phase 1 clinical trials. Introduced to …

News
Press release

Takeda presents positive results from trial of chronic kidney disease treatment

June 10, 2025
Research and Development European Renal Association, Immunology, Nephrology, Takeda, autoimmune disease, immunoglobulin A nephropathy (IgAN), kidney disease

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A …

News
Publishing image

ANGLE’s Parsortix system used in new cancer biology research

June 10, 2025
Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …

News

Hansa Biopharma to host investor event on Guillain-Barré Syndrome to accelerate research

June 10, 2025
Conferencing, Events & Incentives, Interactive Conferences, Medical Communications, Research and Development, Sales and Marketing Guillain-Barré syndrome, Hansa Biopharma, Immunology, Neurology, investor event

Hansa Biopharma (Hansa) will host a virtual investor event on Guillain-Barré syndrome (GBS) on 16 June 2025. The webcast aims …

News

Vertex presents promising new data from cystic fibrosis trials

June 9, 2025
Medical Communications, Research and Development European Cystic Fibrosis Conference, Rare Diseases, Vertex, clinical trial, cystic fibrosis

Vertex Pharmaceuticals has presented new data showing the clinical and quality-of-life benefits of its cystic fibrosis (CF) therapies, particularly Alyftrek …

News
hsm_mobile_clinical_trial_istock-872676342

Corcept reports survival benefit in ALS trial of dazucorilant despite missing primary endpoint

June 9, 2025
Research and Development Corcept Therapeutics, European Network to Cure ALS (ENCALS), Neurology, amyotrophic lateral sclerosis, clinical trial

Corcept Therapeutics has announced results from its phase 2 DAZALS study investigating dazucorilant in patients with amyotrophic lateral sclerosis (ALS), …

News
baby-2416718_1280

Study into treatment for rare condition in premature infants launches globally

June 9, 2025
Research and Development Chiesi Farmaceutici, Elgan Pharma, Gastrointestinal tract, Paediatrics, clinical trial, intestinal malabsorption, premature infant health

Elgan Pharma, specialising in neonatology, and Italy-based biopharma, Chiesi Farmaceutici, have announced the dosing of the first participating infants in …

News

The unbearable lightness of creativity

June 9, 2025
Medical Communications, Sales and Marketing 21GRAMS, Atomic Matter, Corporate, HAVAS LYNX, London UK, PM Society Awards, Pharmacy, pharma healthcare communications, pharma marketing

21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications Commenting on …

Feature
laboratory-testing-az

Trial into rare genetic disease Werner syndrome reports promising results

June 6, 2025
Research and Development Chiba University, Niagen Bioscience, Rare Diseases, Werner Syndrome, clinical trial, rare genetic disease

Researchers at Chiba University, Japan, alongside Niagen Bioscience, have reported successful results from the world’s first trial of nicotinamide riboside …

News

Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine

June 6, 2025
Research and Development Ghent University Hospital, Osivax, Vaccine, Virology, clinical trial, influenza a

Osivax has announced the completion of patient visits in its phase 2a trial evaluating a booster dose of OVX836, a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025